These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 25988740)
1. Neutrophil to lymphocyte ratio and risk of a first episode of stroke in patients with atrial fibrillation: a cohort study. Saliba W; Barnett-Griness O; Elias M; Rennert G J Thromb Haemost; 2015 Nov; 13(11):1971-9. PubMed ID: 25988740 [TBL] [Abstract][Full Text] [Related]
2. The role of CHADS2 and CHA2 DS2 -VASc scores in the prediction of stroke in individuals without atrial fibrillation: a population-based study. Saliba W; Gronich N; Barnett-Griness O; Rennert G J Thromb Haemost; 2016 Jun; 14(6):1155-62. PubMed ID: 27037960 [TBL] [Abstract][Full Text] [Related]
3. The association between red cell distribution width and stroke in patients with atrial fibrillation. Saliba W; Barnett-Griness O; Elias M; Rennert G Am J Med; 2015 Feb; 128(2):192.e11-8. PubMed ID: 25447618 [TBL] [Abstract][Full Text] [Related]
4. Use of neutrophil-lymphocyte ratio for risk stratification and relationship with time in therapeutic range in patients with nonvalvular atrial fibrillation: A pilot study. Cosansu K; Vatan MB; Gunduz H; Akdemir R Clin Cardiol; 2018 Mar; 41(3):339-342. PubMed ID: 29569402 [TBL] [Abstract][Full Text] [Related]
5. Glycated hemoglobin and risk of first episode stroke in diabetic patients with atrial fibrillation: A cohort study. Saliba W; Barnett-Griness O; Elias M; Rennert G Heart Rhythm; 2015 May; 12(5):886-92. PubMed ID: 25614249 [TBL] [Abstract][Full Text] [Related]
7. The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation. Patti G; Sticchi A; Pasceri V; Ricci F; Renda G; Hamrefors V; Melander O; Sutton R; Engström G; De Caterina R; Fedorowski A Diabetes Metab Res Rev; 2019 Jul; 35(5):e3145. PubMed ID: 30790434 [TBL] [Abstract][Full Text] [Related]
8. Association of CHA Hjelholt TJ; Johnsen SP; Brynningsen PK; Pedersen AB J Am Geriatr Soc; 2020 Aug; 68(8):1698-1705. PubMed ID: 32294240 [TBL] [Abstract][Full Text] [Related]
9. Refinement of ischemic stroke risk in patients with atrial fibrillation and CHA2 DS2 -VASc score of 1. Huang D; Anguo L; Yue WS; Yin L; Tse HF; Siu CW Pacing Clin Electrophysiol; 2014 Nov; 37(11):1442-7. PubMed ID: 25039724 [TBL] [Abstract][Full Text] [Related]
10. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation. Saliba W; Rennert G Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101 [TBL] [Abstract][Full Text] [Related]
11. Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores. Esteve-Pastor MA; Marín F; Bertomeu-Martinez V; Roldán-Rabadán I; Cequier-Fillat Á; Badimon L; Muñiz-García J; Valdés M; Anguita-Sánchez M; Intern Med J; 2016 May; 46(5):583-9. PubMed ID: 26929032 [TBL] [Abstract][Full Text] [Related]
12. Augmented intelligence decision tool for stroke prediction combines factors from CHA Horne BD; Jacobs V; May HT; Graves KG; Bunch TJ J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1452-1461. PubMed ID: 31115939 [TBL] [Abstract][Full Text] [Related]
13. Burden of atrial fibrillation: a retrospective review of patients presenting to acute medical services. Jolliffe E; Fu V; Lanford J; Weatherall M; Rosemergy I Intern Med J; 2016 Oct; 46(10):1166-1171. PubMed ID: 27501863 [TBL] [Abstract][Full Text] [Related]
14. CHA Mlodawska E; Tomaszuk-Kazberuk A; Lopatowska P; Kaminski M; Musial WJ Intern Med J; 2017 Mar; 47(3):275-279. PubMed ID: 27860070 [TBL] [Abstract][Full Text] [Related]
15. Risk of ischemic stroke and utility of CHA Tomasdottir M; Friberg L; Hijazi Z; Lindbäck J; Oldgren J Clin Cardiol; 2019 Oct; 42(10):1003-1009. PubMed ID: 31490011 [TBL] [Abstract][Full Text] [Related]
16. Use of preoperative CHA2 DS2 -VASc score to predict the risk of atrial fibrillation after cardiothoracic surgery: a nested case-control study from the Atrial Fibrillation Suppression Trials (AFIST) I, II, and III. Baker WL; Coleman CI; White CM; Kluger J Pharmacotherapy; 2013 May; 33(5):489-95. PubMed ID: 23649811 [TBL] [Abstract][Full Text] [Related]
17. Heart failure: a weak link in CHA Friberg L; Lund LH ESC Heart Fail; 2018 Jun; 5(3):231-239. PubMed ID: 29446254 [TBL] [Abstract][Full Text] [Related]
18. Predictors of stroke or systemic embolism in patients with non-valvular atrial fibrillation with CHA Choi H; Bae MH; Park YJ; Park HK; Lee E; Kim MS; Park JS; Kim HJ; Park BE; Kim HN; Kim N; Lee JH; Jang SY; Yang DH; Park HS; Cho Y Ann Noninvasive Electrocardiol; 2023 Mar; 28(2):e13036. PubMed ID: 36625408 [TBL] [Abstract][Full Text] [Related]
19. CHA Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672 [TBL] [Abstract][Full Text] [Related]
20. Predictive value of neutrophil-to-lymphocyte ratio for atrial fibrillation and stroke in type 2 diabetes mellitus: The Hong Kong Diabetes Study. Chang C; Zhou J; Chou OHI; Chan J; Leung KSK; Lee TTL; Wong WT; Wai AKC; Liu T; Zhang Q; Lee S; Tse G Endocrinol Diabetes Metab; 2023 Jan; 6(1):e397. PubMed ID: 36464326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]